负责丙酮酸脱氢酶激酶2识别二氯乙酸的氨基酸残基。
Amino acid residues responsible for the recognition of dichloroacetate by pyruvate dehydrogenase kinase 2.
作者信息
Klyuyeva Alla, Tuganova Alina, Popov Kirill M
机构信息
Department of Biochemistry and Molecular Genetics, Schools of Medicine and Dentistry, University of Alabama at Birmingham, KAUL 440A, Birmingham, AL 35294, USA.
出版信息
FEBS Lett. 2007 Jun 26;581(16):2988-92. doi: 10.1016/j.febslet.2007.05.052. Epub 2007 May 29.
Abstract
Dichloroacetate (DCA) is a promising anticancer and antidiabetic compound targeting the mitochondrial pyruvate dehydrogenase kinase (PDHK). This study was undertaken in order to map the DCA-binding site of PDHK2. Here, we present evidence that R114, S83, I157 and, to some extent, H115 are essential for DCA binding. We also show that Y80 and D117 are required for the communication between the DCA-binding site and active site of PDHK2. These observations provide important insights into the mechanism of DCA action that may be useful for the design of new, more potent therapeutic compounds.
摘要
二氯乙酸（DCA）是一种有前景的抗癌和抗糖尿病化合物，其作用靶点为线粒体丙酮酸脱氢酶激酶（PDHK）。本研究旨在确定PDHK2的DCA结合位点。在此，我们提供证据表明R114、S83、I157以及在一定程度上的H115对DCA结合至关重要。我们还表明Y80和D117是DCA结合位点与PDHK2活性位点之间通讯所必需的。这些观察结果为DCA作用机制提供了重要见解，可能有助于设计新的、更有效的治疗化合物。
相似文献
1
Amino acid residues responsible for the recognition of dichloroacetate by pyruvate dehydrogenase kinase 2.负责丙酮酸脱氢酶激酶2识别二氯乙酸的氨基酸残基。
FEBS Lett. 2007 Jun 26;581(16):2988-92. doi: 10.1016/j.febslet.2007.05.052. Epub 2007 May 29.
2
Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.基于包含生理和合成配体的人丙酮酸脱氢酶激酶2晶体结构的N端结构域的调控作用。
Biochemistry. 2006 Jan 17;45(2):402-15. doi: 10.1021/bi051402s.
3
Dichloroacetate induces regulatory T-cell differentiation and suppresses Th17-cell differentiation by pyruvate dehydrogenase kinase-independent mechanism.二氯乙酸通过不依赖丙酮酸脱氢酶激酶的机制诱导调节性T细胞分化并抑制辅助性T细胞17分化。
J Pharm Pharmacol. 2017 Jan;69(1):43-51. doi: 10.1111/jphp.12655. Epub 2016 Oct 19.
4
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.AZD7545、二氯乙酸和鬼笔环肽抑制丙酮酸脱氢酶激酶同工型的不同结构机制。
Structure. 2007 Aug;15(8):992-1004. doi: 10.1016/j.str.2007.07.001. Epub 2007 Aug 2.
5
Recognition of the inner lipoyl-bearing domain of dihydrolipoyl transacetylase and of the blood glucose-lowering compound AZD7545 by pyruvate dehydrogenase kinase 2.丙酮酸脱氢酶激酶2对二氢硫辛酰转乙酰基酶的内部含硫辛酰结构域和降血糖化合物AZD7545的识别。
Biochemistry. 2007 Jul 24;46(29):8592-602. doi: 10.1021/bi700650k. Epub 2007 Jun 30.
6
Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.液相色谱-串联质谱法揭示，不同丙酮酸脱氢酶激酶抑制剂处理肺癌细胞后，其代谢产物图谱存在明显差异。
J Proteome Res. 2018 Sep 7;17(9):3012-3021. doi: 10.1021/acs.jproteome.8b00184. Epub 2018 Jul 31.
7
Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.二氯醋酸盐的抗肿瘤和化疗增敏作用涉及肿瘤微环境的调节：涉及重新组织的葡萄糖代谢、细胞存活调节和巨噬细胞分化的作用。
Toxicol Appl Pharmacol. 2013 Nov 15;273(1):196-208. doi: 10.1016/j.taap.2013.09.005. Epub 2013 Sep 17.
8
Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.C 末端 DW 基序在二氯乙酸介导的丙酮酸脱氢酶激酶 2 抑制中起关键作用。
J Biol Chem. 2009 Dec 4;284(49):34458-67. doi: 10.1074/jbc.M109.065557. Epub 2009 Oct 15.
9
Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.苯丁酸盐对丙酮酸脱氢酶激酶的差异性抑制作用以及与二氯乙酸联合使用对丙酮酸脱氢酶复合体活性的增强作用。
J Inherit Metab Dis. 2015 Sep;38(5):895-904. doi: 10.1007/s10545-014-9808-2. Epub 2015 Jan 20.
10
Allosteric coupling in pyruvate dehydrogenase kinase 2.丙酮酸脱氢酶激酶2中的变构偶联
Biochemistry. 2008 Aug 12;47(32):8358-66. doi: 10.1021/bi800631h. Epub 2008 Jul 16.
引用本文的文献
1
Two dichloric compounds inhibit in vivo U87 xenograft tumor growth.两种二氯化物化合物抑制体内 U87 异种移植肿瘤生长。
Cancer Biol Ther. 2019;20(9):1281-1289. doi: 10.1080/15384047.2019.1632131. Epub 2019 Jun 24.
2
Targeting Cancer Metabolism - Revisiting the Warburg Effects.靶向癌症代谢——重新审视瓦伯格效应
Toxicol Res. 2016 Jul;32(3):177-93. doi: 10.5487/TR.2016.32.3.177. Epub 2016 Jul 30.
3
Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.肺动脉高压分子基础的新观念：第一部分：肺动脉高压时肺循环及右心室的代谢可塑性与线粒体动力学
Circulation. 2015 May 12;131(19):1691-702. doi: 10.1161/CIRCULATIONAHA.114.006979.
4
Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.C 末端 DW 基序在二氯乙酸介导的丙酮酸脱氢酶激酶 2 抑制中起关键作用。
J Biol Chem. 2009 Dec 4;284(49):34458-67. doi: 10.1074/jbc.M109.065557. Epub 2009 Oct 15.
5
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.AZD7545、二氯乙酸和鬼笔环肽抑制丙酮酸脱氢酶激酶同工型的不同结构机制。
Structure. 2007 Aug;15(8):992-1004. doi: 10.1016/j.str.2007.07.001. Epub 2007 Aug 2.
本文引用的文献
1
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.线粒体 - 钾离子通道轴在癌症中受到抑制，使其正常化可促进细胞凋亡并抑制癌症生长。
Cancer Cell. 2007 Jan;11(1):37-51. doi: 10.1016/j.ccr.2006.10.020.
2
Ligand-induced effects on pyruvate dehydrogenase kinase isoform 2.配体对丙酮酸脱氢酶激酶同工型2的诱导作用。
J Biol Chem. 2006 May 5;281(18):12568-79. doi: 10.1074/jbc.M513514200. Epub 2006 Mar 3.
3
Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.基于包含生理和合成配体的人丙酮酸脱氢酶激酶2晶体结构的N端结构域的调控作用。
Biochemistry. 2006 Jan 17;45(2):402-15. doi: 10.1021/bi051402s.
4
Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.与人类丙酮酸脱氢酶复合体的硫辛酰结构域2结合的丙酮酸脱氢酶激酶3的晶体结构
EMBO J. 2005 May 18;24(10):1763-74. doi: 10.1038/sj.emboj.7600663. Epub 2005 Apr 28.
5
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
6
Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation.通过可逆磷酸化对丙酮酸脱氢酶复合体活性的调节。
Biochem Soc Trans. 2003 Dec;31(Pt 6):1143-51. doi: 10.1042/bst0311143.
7
Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex.丙酮酸脱氢酶激酶的各个同工酶与丙酮酸脱氢酶复合体转乙酰酶组分的含硫辛酰胺的内部结构域之间的相互作用。
Biochem J. 2002 Aug 15;366(Pt 1):129-36. doi: 10.1042/BJ20020301.
8
Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms.丙酮酸脱氢酶激酶和磷酸酶同工型的独特调节特性。
Prog Nucleic Acid Res Mol Biol. 2001;70:33-75. doi: 10.1016/s0079-6603(01)70013-x.
9
Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites.通过多位点磷酸化对丙酮酸脱氢酶活性进行调节。
Biochem J. 2001 Aug 15;358(Pt 1):69-77. doi: 10.1042/0264-6021:3580069.
10
Structure of pyruvate dehydrogenase kinase. Novel folding pattern for a serine protein kinase.丙酮酸脱氢酶激酶的结构。丝氨酸蛋白激酶的新型折叠模式。
J Biol Chem. 2001 Oct 5;276(40):37443-50. doi: 10.1074/jbc.M104285200. Epub 2001 Aug 1.
Zotero 插件